Option Care Health (NASDAQ:OPCH) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS

Option Care Health (NASDAQ:OPCH - Get Free Report) issued its earnings results on Tuesday. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.04, Briefing.com reports. The firm had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company's revenue was up 16.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.26 EPS. Option Care Health updated its FY 2025 guidance to 1.610-1.700 EPS.

Option Care Health Stock Down 0.4 %

NASDAQ:OPCH traded down $0.14 during trading hours on Thursday, hitting $32.17. 3,984,063 shares of the company traded hands, compared to its average volume of 1,819,874. The company has a market cap of $5.28 billion, a PE ratio of 27.03, a PEG ratio of 2.30 and a beta of 1.07. Option Care Health has a one year low of $21.39 and a one year high of $35.53. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The firm's 50-day simple moving average is $33.34 and its 200-day simple moving average is $28.83.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on OPCH shares. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and raised their price objective for the company from $38.00 to $40.00 in a report on Wednesday. JPMorgan Chase & Co. lifted their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. JMP Securities reissued a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a research report on Tuesday, April 22nd. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and boosted their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, Barrington Research reiterated an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a report on Wednesday. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, Option Care Health has a consensus rating of "Moderate Buy" and an average target price of $35.50.

Insider Transactions at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.64% of the company's stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.